The global Inactivated Porcine Atrophic Rhinitis Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. This report aims to provide a comprehensive presentation of the global market for Inactivated Porcine Atrophic Rhinitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Porcine Atrophic Rhinitis Vaccine. This report contains market size and forecasts of Inactivated Porcine Atrophic Rhinitis Vaccine in global, including the following market information:
Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tissue Culture Origin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Inactivated Porcine Atrophic Rhinitis Vaccine include Merck Animal Health, HIPRA, Bioveta, China Animal Husbandy Industry, Wuhan Keqian Biology, Pulike Bio-Engineering, Tiankang Animal Science Bio-Technology and Tianjin Ringpu Bio-Technology, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Inactivated Porcine Atrophic Rhinitis Vaccine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inactivated Porcine Atrophic Rhinitis Vaccine Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Segment Percentages, by Type, 2022 (%)
- Tissue Culture Origin
- Cell Line Origin
Global Inactivated Porcine Atrophic Rhinitis Vaccine Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Segment Percentages, by Application, 2022 (%)
Global Inactivated Porcine Atrophic Rhinitis Vaccine Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Inactivated Porcine Atrophic Rhinitis Vaccine revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Inactivated Porcine Atrophic Rhinitis Vaccine revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck Animal Health
- HIPRA
- Bioveta
- China Animal Husbandy Industry
- Wuhan Keqian Biology
- Pulike Bio-Engineering
- Tiankang Animal Science Bio-Technology
- Tianjin Ringpu Bio-Technology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Inactivated Porcine Atrophic Rhinitis Vaccine, market overview.
Chapter 2: Global Inactivated Porcine Atrophic Rhinitis Vaccine market size in revenue.
Chapter 3: Detailed analysis of Inactivated Porcine Atrophic Rhinitis Vaccine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inactivated Porcine Atrophic Rhinitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Inactivated Porcine Atrophic Rhinitis Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Overall Market Size
2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size: 2022 VS 2032
2.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Inactivated Porcine Atrophic Rhinitis Vaccine Players in Global Market
3.2 Top Global Inactivated Porcine Atrophic Rhinitis Vaccine Companies Ranked by Revenue
3.3 Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Inactivated Porcine Atrophic Rhinitis Vaccine Companies in Global Market, by Revenue in 2022
3.5 Global Companies Inactivated Porcine Atrophic Rhinitis Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Inactivated Porcine Atrophic Rhinitis Vaccine Players in Global Market
3.6.1 List of Global Tier 1 Inactivated Porcine Atrophic Rhinitis Vaccine Companies
3.6.2 List of Global Tier 2 and Tier 3 Inactivated Porcine Atrophic Rhinitis Vaccine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Markets, 2022 & 2032
4.1.2 Tissue Culture Origin
4.1.3 Cell Line Origin
4.2 By Type - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue & Forecasts
4.2.1 By Type - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, 2024-2032
4.2.3 By Type - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2022 & 2032
5.1.2 Sows
5.1.3 Gilts
5.2 By Application - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue & Forecasts
5.2.1 By Application - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, 2024-2032
5.2.3 By Application - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2022 & 2032
6.2 By Region - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue & Forecasts
6.2.1 By Region - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, 2024-2032
6.2.3 By Region - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, 2018-2032
6.3.2 US Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.3.3 Canada Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.3.4 Mexico Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, 2018-2032
6.4.2 Germany Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.4.3 France Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.4.4 U.K. Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.4.5 Italy Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.4.6 Russia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.4.7 Nordic Countries Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.4.8 Benelux Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, 2018-2032
6.5.2 China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.5.3 Japan Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.5.4 South Korea Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.5.5 Southeast Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.5.6 India Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, 2018-2032
6.6.2 Brazil Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.6.3 Argentina Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, 2018-2032
6.7.2 Turkey Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.7.3 Israel Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.7.4 Saudi Arabia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
6.7.5 UAE Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, 2018-2032
7 Inactivated Porcine Atrophic Rhinitis Vaccine Companies Profiles
7.1 Merck Animal Health
7.1.1 Merck Animal Health Company Summary
7.1.2 Merck Animal Health Business Overview
7.1.3 Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Major Product Offerings
7.1.4 Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in Global Market (2018-2023)
7.1.5 Merck Animal Health Key News & Latest Developments
7.2 HIPRA
7.2.1 HIPRA Company Summary
7.2.2 HIPRA Business Overview
7.2.3 HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Major Product Offerings
7.2.4 HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in Global Market (2018-2023)
7.2.5 HIPRA Key News & Latest Developments
7.3 Bioveta
7.3.1 Bioveta Company Summary
7.3.2 Bioveta Business Overview
7.3.3 Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Major Product Offerings
7.3.4 Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in Global Market (2018-2023)
7.3.5 Bioveta Key News & Latest Developments
7.4 China Animal Husbandy Industry
7.4.1 China Animal Husbandy Industry Company Summary
7.4.2 China Animal Husbandy Industry Business Overview
7.4.3 China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Major Product Offerings
7.4.4 China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in Global Market (2018-2023)
7.4.5 China Animal Husbandy Industry Key News & Latest Developments
7.5 Wuhan Keqian Biology
7.5.1 Wuhan Keqian Biology Company Summary
7.5.2 Wuhan Keqian Biology Business Overview
7.5.3 Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Major Product Offerings
7.5.4 Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in Global Market (2018-2023)
7.5.5 Wuhan Keqian Biology Key News & Latest Developments
7.6 Pulike Bio-Engineering
7.6.1 Pulike Bio-Engineering Company Summary
7.6.2 Pulike Bio-Engineering Business Overview
7.6.3 Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Major Product Offerings
7.6.4 Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in Global Market (2018-2023)
7.6.5 Pulike Bio-Engineering Key News & Latest Developments
7.7 Tiankang Animal Science Bio-Technology
7.7.1 Tiankang Animal Science Bio-Technology Company Summary
7.7.2 Tiankang Animal Science Bio-Technology Business Overview
7.7.3 Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Major Product Offerings
7.7.4 Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in Global Market (2018-2023)
7.7.5 Tiankang Animal Science Bio-Technology Key News & Latest Developments
7.8 Tianjin Ringpu Bio-Technology
7.8.1 Tianjin Ringpu Bio-Technology Company Summary
7.8.2 Tianjin Ringpu Bio-Technology Business Overview
7.8.3 Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Major Product Offerings
7.8.4 Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in Global Market (2018-2023)
7.8.5 Tianjin Ringpu Bio-Technology Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Inactivated Porcine Atrophic Rhinitis Vaccine Market Opportunities & Trends in Global Market
Table 2. Inactivated Porcine Atrophic Rhinitis Vaccine Market Drivers in Global Market
Table 3. Inactivated Porcine Atrophic Rhinitis Vaccine Market Restraints in Global Market
Table 4. Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine in Global Market
Table 5. Top Inactivated Porcine Atrophic Rhinitis Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Share by Companies, 2018-2023
Table 8. Global Companies Inactivated Porcine Atrophic Rhinitis Vaccine Product Type
Table 9. List of Global Tier 1 Inactivated Porcine Atrophic Rhinitis Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inactivated Porcine Atrophic Rhinitis Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2024-2032
Table 30. Merck Animal Health Company Summary
Table 31. Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Product Offerings
Table 32. Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Animal Health Key News & Latest Developments
Table 34. HIPRA Company Summary
Table 35. HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Product Offerings
Table 36. HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (US$, Mn) & (2018-2023)
Table 37. HIPRA Key News & Latest Developments
Table 38. Bioveta Company Summary
Table 39. Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Product Offerings
Table 40. Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (US$, Mn) & (2018-2023)
Table 41. Bioveta Key News & Latest Developments
Table 42. China Animal Husbandy Industry Company Summary
Table 43. China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Product Offerings
Table 44. China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (US$, Mn) & (2018-2023)
Table 45. China Animal Husbandy Industry Key News & Latest Developments
Table 46. Wuhan Keqian Biology Company Summary
Table 47. Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Product Offerings
Table 48. Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (US$, Mn) & (2018-2023)
Table 49. Wuhan Keqian Biology Key News & Latest Developments
Table 50. Pulike Bio-Engineering Company Summary
Table 51. Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Product Offerings
Table 52. Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (US$, Mn) & (2018-2023)
Table 53. Pulike Bio-Engineering Key News & Latest Developments
Table 54. Tiankang Animal Science Bio-Technology Company Summary
Table 55. Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Product Offerings
Table 56. Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (US$, Mn) & (2018-2023)
Table 57. Tiankang Animal Science Bio-Technology Key News & Latest Developments
Table 58. Tianjin Ringpu Bio-Technology Company Summary
Table 59. Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Product Offerings
Table 60. Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (US$, Mn) & (2018-2023)
Table 61. Tianjin Ringpu Bio-Technology Key News & Latest Developments
List of Figures
Figure 1. Inactivated Porcine Atrophic Rhinitis Vaccine Segment by Type in 2022
Figure 2. Inactivated Porcine Atrophic Rhinitis Vaccine Segment by Application in 2022
Figure 3. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in 2022
Figure 8. By Type - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share, 2018-2032
Figure 9. By Application - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share, 2018-2032
Figure 10. By Type - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share, 2018-2032
Figure 12. By Application - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share, 2018-2032
Figure 14. By Region - Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share, 2018-2032
Figure 15. By Country - North America Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share, 2018-2032
Figure 16. US Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share, 2018-2032
Figure 20. Germany Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 21. France Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share, 2018-2032
Figure 28. China Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 32. India Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share, 2018-2032
Figure 34. Brazil Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share, 2018-2032
Figure 37. Turkey Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Inactivated Porcine Atrophic Rhinitis Vaccine Revenue, (US$, Mn), 2018-2032
Figure 41. Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
